Foundation for innovation
in Cardiometabolism and Nutrition

Enhanced Therapeutic Outcomes with Atezolizumab-Bevacizumab and SIRT Combination compared to SIRT alone in Unresectable HCC: A Promising Approach for Improved Survival

Clinics and Research in Hepatology and Gastroenterology

Enhanced Therapeutic Outcomes with Atezolizumab-Bevacizumab and SIRT Combination compared to SIRT alone in Unresectable HCC: A Promising Approach for Improved Survival

Publié le 

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau